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Summary 
protein. Gene transfer-mediated elevations in the levels 
of this Bcl-2-binding protein can prolong cell survival in 
some circumstances and also can cooperate with Bcl-2 
in the suppression of apoptosis. These properties suggest 
that the gene encoding this protein represents a novel type 
of anti-cell death gene, which we have termed BAG-l, 
for Bcl-2-associated athanogene 1 (from the Greek word 
athanos, which refers to anti-death). 
Using a protein interaction cloning technique, we iden- 
tified cDNAs that encode a novel Bcl-2-binding protein, 
termed BAG-l. The BAG-1 protein shares no signifi- 
cant homology with Bci-2 or other Bcl-2 family pro- 
teins, which can form homo- and heterodimers. In 
gene transfer experiments using a human lymphoid 
cell line, Jurkat, coexpression of BAG-1 and Bcl-2 pro- 
vided markedly increased protection from cell death 
induced by several stimuli, including staurosporine, 
anti-Fas antibody, and cytolytic T cells, relative to cells 
that contained gene transfer-mediated elevations in 
either BAG-1 or Bcl-2 protein alone. BAG-transfected 
3T3 fibroblasts also exhibited prolonged cell survival 
in response to an apoptotic stimulus. The findings indi- 
cate that bag.1 represents a new type of anti-cell death 
gene and suggest that some routes of apoptosis induc- 
tion previously ascribed to Bcl-2-independent path- 
ways may instead reflect a need for the combination 
of Bcl-2 and BAG-l. 
Introduction 
Cell death plays an important role in a wide variety of 
physiological circumstances in essentially all complex 
multicellular organisms (reviewed by Ellis et al., 1991). 
Several genes have been identified that participate as ei- 
ther inducers or repressors of programmed cell death. 
Among these is bcl-2 (for B cell lymphoma 2), a blocker 
of cell death that was first discovered by virtue of its 
involvement in the t(14;18) chromosomal translocations 
found in the majority of non-Hodgkin's B cell lymphomas 
(Tsujimoto and Croce, 1986). Gene transfer-mediated ele- 
vations in Bcl-2 protein levels have been shown to render 
cells relatively more resistant to induction of apoptosis by 
a.n impressive variety of stimuli and insults, suggesting 
that this protein regulates a distal step in a final common 
pathway for apoptotic cell death (reviewed by Reed, 1994). 
Furthermore, elements of this pathway appear to be well 
conserved throughout evolution (Vaux et al., 1992b; Hen- 
gartner and Horvitz, 1994). 
The biochemical mechanism of action of the Bcl-2 pro- 
tein remains enigmatic, principally because its predicted 
amino acid sequence shares no significant homology with 
other proteins whose functions are known. For this reason, 
we have attempted to identify proteins that can bind to 
Bcl-2. Here we describe the molecular cloning and func- 
tional characterization of cDNAs encoding a novel protein 
that interacts physically and functionally with the Bcl-2 
Results 
Molecular Cloning of cDNAs for BAG-1 
To identify cDNAs encoding proteins that can bind to Bcl-2, 
a mouse embryo cDNA library in a X phage expression 
vector was screened with recombinant human Bcl-2 pro- 
tein. Phage clones that produced proteins capable of bind- 
ing to recombinant Bcl-2 protein were then detected by 
incubation of filters with a human-specific anti-Bcl-2 mono- 
clonal antibody, resulting in a single positive clone from 
a screen of - 106 phage clones. DNA sequencing revealed 
an 830 bp insert, containing a 630 bp coding region in- 
frame with the upstream T7/10 protein sequences derived 
from the XEX-lox cloning vector. 
BAG-1 Protein Specifically Interacts with Bcl-2 
In Vitro 
An immobilized protein interaction (Far Western blot) 
assay was performed to confirm the ability of recombinant 
Bcl-2 protein to bind to BAG-1 protein. The bag-1 partial 
cDNA described above was subcloned into the plasmid 
pGEX-3X and expressed in Escherichia coil as a GST- 
BAG-1 fusion protein. GST-BAG-1 and GST nonfusion 
protein were compared with regards to binding of baculovi- 
rus-produced Bcl-2, using the same filter binding assay 
employed for library screening. As shown in Figure 1A, 
Bcl-2 bound to GST-BAG-1 but not to GST protein. In 
this experiment, cell lysates from a murine lymphoid cell, 
$49.1, that had been stably infected with a recombinant 
retrovirus encoding human Bcl-2 protein (S49.1-BCL-2) 
or a control retrovirus ($49.1-NEO) (Miyashita and Reed, 
1992) were also included. The prominent -26  kDa band 
seen in S49-BCL-2 cell lysates represents direct binding of 
the anti-human Bcl-2 monoclonal antibody 4D7 to human 
Bcl-2 protein in the S49.1-BCL-2 cells, thus serving as 
a control for the antibody detection system. In addition, 
however, a faint band at -28 -30  kDa was also seen in 
both S49.1-BCL-2 and $49.1-NEO cells that may repre- 
sent binding of recombinant Bcl-2 protein to endogenous 
BAG-1 protein (see below). As a control, Far Western blot 
analysis was performed using Sf9 lysates derived from 
cells infected with a 13-galactosidase (13-gal)-expressing ba- 
culovirus (Figure 1A, right). 
To determine whether the interaction of BAG-1 with 
Bcl-2 can also take place in solution, soluble GST-BAG-1 
and GST control proteins were immobilized on glutathi- 
one-Sepharose and then incubated with lysates prepared 
from Sf9 cells that had been infected with either Bcl-2- 
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Figure 1. Interaction of Bcl-2 with BAG-1 Fusion Proteins 
(A) Purified GST-BAG-1 (amino acids 8-219) fusion and GST nonfu- 
sion proteins (1~g) and etergent lysates prepared from 106 S49-NEO 
and S49-BCL-2 cells were subjected to SDS-PAGE and transferred 
to nitrocellulose. The resulting filters were incubated with 1% (v/v) Sf9 
lysates derived from cells infected with either Bcl-2 (left) or 13-gal (right) 
baculoviruses, followed by anti-Bcl-2 antibody, which was detected by 
using an alkaline phosphatase-conjugated s condary antibody. 
(B) GST-BAG-1 fusion and GST nonfusion proteins were immobilized 
on glutathione-Sepharose ( -  2.5 ~,g) and mixed with 500 ~,g of deter- 
gent lysates prepared from Sf9 cells infected with either Bcl-2 or .B-gal- 
producing baculoviruses. The Sepharose beads were then washed 
extensively and associated proteins analyzed by SDS-PAGE/immu- 
noblot assay using a Bcl-2-specific antiserum. 
producing or control 13-gal baculovirus. After the beads 
were washed, associated proteins were analyzed by im- 
munoblotting using a Bcl-2-specific antibody (Reed et al., 
1991). As shown, Bcl-2 protein was specifically recovered 
from Sf9 cell lysates on GST-BAG-1 Sepharose but not 
on beads that contained GST control protein (Figure 1B). 
Though the data are not presented here, Bcl-2 also did 
not associate with several other control GST fusion pro- 
teins. The interaction of BAG-1 with Bcl-2 was also con- 
firmed by a yeast two-hybrid method (data not shown). 
Predicted Amino Acid Sequence of BAG-1 Reveals 
a Novel Protein 
Using the partial bag-1 cDNA as a hybridization probe 
for cDNA library screening, we obtained additional bag-I 
cDNAs, thus deducing the complete open reading frame 
for the 219 amino acid mouse BAG-1 protein (Figure 2). 
BAG-1 is novel and shares no similarity with Bcl-2 or its 
homologous proteins. The BAG-1 protein is acidic (pre- 
dicted pl, 4.81) and contains multiple glutamic acid resi- 
dues (31 of 219). Although this raised the possibility of 
Ca 2÷ binding, no clear homology was observed with other 
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Figure 2. Predicted Amino Acid Sequence of BAG-1 Protein 
The predicted amino acid sequence of the encoded BAG-1 protein is 
presented. 
Ca2+-binding proteins of either the EF-hand or non-EF- 
hand type. A region in the mouse BAG-1 protein (residues 
37-73) shows as much as 50% amino acid sequence iden- 
tity (66% similarity) with several ubiquitin and ubiquitin-like 
proteins. The region from amino acid - 100 to amino acid 
- 212 is predicted to assume a largely m-helical conforma- 
tion and contains segments that on Edmundson wheel 
plots are predicted to be amphipathic in nature and thus 
good candidates for participation i  coiled-coil interactions 
with other proteins. Kyte-Doolittle plots failed to reveal 
any hydrophobic domains in BAG-1 that would suggest 
the presence of a transmembrane domain or hydrophobic 
leader sequence. 
Gene Transfer Analysis of BAG-1 Function Reveals 
Anti-Cell Death Activity 
A cDNA encoding full-length BAG-1 protein was subcloned 
into a mammalian expression plasmid, pCEP-4, that con- 
tains a hygromycin phosphotransferase gene and was in- 
troduced into Jurkat T cell lines that had previously been 
stably transfected with either a bcl-2 (pZip-Bcl-2) or a con- 
trol (pZip-NEO) expression plasmid (Torigoe et al., 1994a, 
1994b). After selection in hygromycin, the BAG-1 transfec- 
tant cells were analyzed by immunoblotting using BAG-I- 
and Bcl-2-specific anti-peptide antisera. Elevated levels 
of BAG-1 protein were detected in the Jurkat-Bcl-2 and 
Jurkat-NEO transfectants that received the pCEP-4-  
BAG-1 ptasmid but not those that were transfected with 
pCEP-4 parental control plasmid (Figure 3, left). Despite 
a predicted molecular mass of - 24.5 kDa, note that the 
BAG-1 protein migrates as a -29-30  kDa protein, pre- 
sumably owing to its acidic nature. As expected, Bcl-2 
protein levels were markedly elevated in the Jurkat-Bcl-2 
cells as compared with Jurkat-NEO cells (Figure 3, right). 
We next explored the relative sensitivity of these doubly 
transfected T cells to induction of apoptosis by several 
stimuli. As shown in Figure 4, Jurkat T cells with gene 
transfer-mediated elevations in Bcl-2 protein were par- 
tially resistant to cytotoxicity induced by 1 p~g/ml anti-Fas 
antibody. In contrast with Bcl-2, gene transfer-mediated 
elevations in BAG-1 by themselves had essentially no ef- 
fect on the relative sensitivity of Jurkat T cells to anti-Fas- 
induced cytotoxicity. In combination with Bcl-2, however, 
elevations in BAG-1 protein levels resulted in markedly 
enhanced resistance to anti-Fas-induced apoptosis. Simi- 
lar conclusions were reached on the basis of experiments 
where the protein kinase inhibitor staurosporine was em- 
ployed to induce apoptosis in Jurkat T cells. As shown in 
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Figure 3. Immunoblot Analysis of BAG-1-Transfected Jurkat T Cells 
Protein from cell lysates (50 p,g) was subjected to SDS-PAGE/immu- 
noblot analysis using either anti-BAG-1 (left) or anti-Bcl-2 antiserum 
(right). The arrows indicate the positions of the BAG-1 and Bcl-2 pro- 
teins. Control-transfected Jurkat cells (C) contained the pZip-NEO 
and pCEP-4 plasmids without inserted bcl-2 or bag-1 cDNAs. 
Figure 4, BAG-1 alone provided only slightly enhanced 
protection from staurosporine-induced cell death. Bcl-2 
was partially protective, with less than half of the cells still 
alive after 2 days. In contrast, the combination of BAG-1 
and Bcl-2 afforded marked resistance to staurosporine- 
induced cell death, with -80% of the cells surviving a 
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Figure 4. BAG-1 Cooperates with Bcl-2 to Increase Resistance to Cell 
Death in Jurkat T Cells 
Transfected Jurkat cells were cultured at 5 x 105 cells/ml in complete 
medium containing either 1 ~g/ml of anti-Fas monoclonal antibody 
2D1 (top) or 10 p.M staurosporine (middle). The percentage viable cells 
were then determined at various times thereafter by trypan blue dye 
exclusion. Equivalent data were obtained using MTT assays (data not 
shown). Jurkat cells were labeled with SlCr (bottom) and mixed with 
CTLL-2 cytolytic T cells that had been transfected with expression 
plasmids, producing constitutively activated Lck kinase (Tyr~ 
Phe505), normal Lck kinase, or neo control plasmid alone. Specific Cr 
release was measured 4 hr later. All data represent mean -- standard 
deviation (n = 3). 
day treatment w;th t 0 ~M staurospor;ne. The d;fferential 
survival of these Jurkat T cell transfectants was not attrib- 
utable to variations in rates of spontaneous cell death, 
since cell viability was >95% for all four cell lines when 
cultured for up to 3 or 4 days without anti-Fas antibody 
or other stimuli. Comparable results were obtained when 
several independent clones of tranfected J u rkat cells were 
evaluated (data not shown). 
Next, Jurkat cells were labeled with 51Cr and then co- 
cultured with cloned cytolytic T cells. Specific cytotoxic 
T lymphocyte (CTL)-induced slCr release was then moni- 
tored in standard 4 hr cytotoxicity assays. These cloned 
T cells were previously shown to exhibit lymphokine- 
activated killer (LAK)-Iike cytolytic activity against Jurkat 
and certain other tumor cell lines through a CD3- and major 
histocompatibility complex-independent mechanism (Tori- 
goe et al., 1994a, 1994b). Some of these cytolytic T cells 
had been stably transfected with expression plasmids en- 
coding normal Lck kinase (N-Lck) or a constitutively active 
mutant version of Lck (A-Lck), since our previous investi- 
gations demonstrated that elevated levels of Lck kinase 
activity can enhance cytolytic T cell killing by increasing 
secretion of cytotoxic granules and expression of cell ad- 
hesion proteins (Torigoe et al., 1994a). Jurkat cells with 
elevations in BAG-1 protein exhibited some slight but re- 
producible (n = 3) resistance to lysis induced by CTLs. 
Jurkat cells with elevated levels of Bcl-2 protein were rela- 
tively more resistant han the BAG-1 transfectants, but not 
as resistant as Jurkat cells that contained gene transfer- 
mediated elevations in both Bcl-2 and BAG-1 proteins. 
Depending on the particular CTL clone examined, Jurkat 
cells overexpressing the combination of Bcl-2 and BAG-1 
experienced only 16%-23% as much lysis as control- 
transfected Jurkat cells, compared with 76%-79% for the 
BAG-1 single transfectants and 40o--50% for the Bcl-2 
single transfectants. Taken together, these data indicate 
that BAG-1 can augment the anti-cell death function of 
Bcl-2. 
Analysis of BAG-1 Function in 3T3 Fibroblasts 
In contrast with Jurkat T cells where BAG-1 alone only 
marginally enhanced cell survival, gene transfer studies 
using BALB/c 3T3 fibroblasts suggested that BAG-1 can 
have significant anti-cell death activity in some cells even 
when transfected without Bcl-2 expression plasmids. In 
these experiments, 3T3 cells were stably transfected ei- 
ther with the BAG-1 expression plasmid pRc/CMV-BAG-1 
or with the pRc-CMV plasmid lacking an inserted bag-1 
cDNA. For comparison, 3T3 cells were also transfected 
with a Bcl-2 expression plasmid. Initially, a polyclonal ine 
of G418-resistant BAG-1 transfectants was obtained but 
found to contain BAG-1 protein at levels not detectably 
above those seen in control-transfected 3T3 cells (lanes 
1 and 2 of Figure 5). Individual clones from this bulk- 
transfected line were therefore obtained and some identi- 
fied that had elevations in BAG-1 protein, presumably re- 
flecting integration of the plasmid DNA into sites favorable 
for expression. The clone shown in Figure 5 (lane 3; clone 
number 19), for instance, contained -3-fold higher levels 
of BAG-1 than the NEO control transfectants (lane 2). In 
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Figure 5. Expression and Function of BAG-1 in BALB/c 3T3 Cells 
BALB/c 3T3 cells were stably transfected with pRc/CMV-BAG-1 (lane 1), 
pRc/CMV (lane 2), pZip-NEO (lane 5), or pZip-Bcl-2 (lane 6) plasmid 
DNAs. In some cases, independent clones were isolated from the pRc/ 
CMV-BAG-l-transfected line: clones number 19 (lane 3) and number 
28 (lane 4). Immunoblot analysis was performed (30 p.g of cellular 
proteins) using antibodies pecific for either the BAG-1 (lanes 1-4) or 
human Bcl-2 (lanes 5-7) proteins and using an ECL method. The t(14; 
18)-containing line RS11846 was included as a positive control (lane 
7) for Bcl-2. The blot (lanes 1-4) was subsequently incubated with an 
antiserum specific for FI-~,-ATPase (detected by a colorimetric assay) 
to verify loading of equal amounts of protein. 
At top, 3T3 transfectants were cultured at 104 cells/well (50%-70% 
confluent) for various times with 1 p.M staurosporine, and the relative 
number of viable cells was determined by MIF assay and expressed 
as a control relative to untreated cells at the initiation of the experiment 
(mean _ standard eviation; n = 3). 
many other G418-resistant clones, however, the levels of 
BAG-1 protein were essentially unchanged from baseline 
(clone number 28, for example; lane 4 of Figure 5). 
Previously we showed that the protein kinase inhibitor 
staurosporine is a potent inducer of apoptosis in fibroblast 
cell lines (Jacobson et al., 1993), often producing more 
synchronous and reproducible cell death kinetics than se- 
rum withdrawal. We therefore challenged BAG-1 and con- 
trol-transfected 3T3 cells with 1 p.M staurosporine and 
monitored cell survival at various times thereafter. As 
shown, for example, by the results obtained with the BAG-1- 
overexpressing clone 19, gene transfer-mediated eleva- 
tions in BAG-1 protein prolonged the survival of BALB/c 
3T3 cells relative to other clones, such as clone 28, which 
had been transfected with the same bag-1 cDNA-con- 
taining plasmid but failed to produce higher levels of 
BAG-1 protein (Figure 5). This prolongation of cell survival 
was typically similar to that seen for 3T3 cells that had 
been stably transfected with a Bcl-2-encoding expression 
plasmid. 
Discuss ion  
Using a protein interaction cloning technique, we have 
identified cDNAs encoding a novel Bcl-2-binding protein. 
With the exception of a ubiquitin-like domain, the predicted 
amino acid sequence of BAG-1 has no clear similarity to 
other known proteins and contains no motifs that would 
indicate a biochemical function for this protein. BAG-1 
therefore may represent the prototype of a novel type of 
anti-cell death gene. Although Bcl-2 has been shown to 
bind to several homologous proteins, including Bax (for 
Bcl-2-associated x protein), Bcl-x,, Bcl-xs, and Mcll (Sato 
et al., 1994; Oltvai et al., 1993), BAG-1 lacks sequence 
homology with Bcl-2 and its related proteins. All Bcl-2 ho- 
mologs identified thus far contain significant amino acid 
similarity in at least one of three well-conserved domains, 
which we have previously designated Bcl-2 domains A, 
B, and C (Sato et al., 1994). The BAG-1 protein lacks simi- 
larity to all three of these conserved domains, indicating 
that it is not a member of the Bcl-2 protein family. 
BAG-1 contains a domain located at residues 37-73 that 
has sequence similarity with several ubiquitin and ubiqui- 
tin-like proteins, including the human and mouse Gdx-1 
protein (50%, 43s/o), baculovirus ubiquitin-like protein 
(46%), and the mouse Nedd8 gene (36%). Ubiquitin is a 
small 76 amino acid protein that is well conserved through- 
out evolution and that becomes covalently attached to pro* 
teins, typically as part of a nonlysosomal, ATP-dependent 
protein degradation pathway (reviewed by Hershko and 
Ciechanover, 1992; Rechsteiner, 1991). Ubiquitins con- 
tain a conserved lysine at position 48 that provides an 
amino acceptor group for covalent ligation to the car- 
boxyl group of the C-terminal glycine of other ubiquitin 
molecules during the formation of branch chain ubiquitin- 
ubiquitin conjugates on target proteins. Interestingly, a 
lysine is found at position 67 within the ubiquitin-like do- 
main of BAG-1 that corresponds to lysine 48 of ubiquitin. 
Internal lysines have also been shown to be the sites of 
ubiquitin conjugation in some other proteins that become 
polyubiquitinated and thereby targeted for degradation. 
Thus, one possible role of the ubiquitin-like domain i  
BAG-1 may be to serve as a site for attachment of ubiquitin 
and subsequent proteolytic degradation. In this regard, 
ubiquitin conjugation has been shown to regulate the turn- 
over of other proteins that are either known or thought to 
play a role in cell death regulation in mammals, including 
the tumor suppressor p53 and some cyclins (Rechsteiner, 
1991 ; Hershco and Ciechanover, 1992). In addition, previ- 
ous studies using antisense approaches have docu- 
mented a requirement for ubiquitin for apoptosis induced 
by "y-radiation in thymocytes (Delic et al., 1993). Inasmuch 
as this ubiquitin-like domain may be involved in targeting 
BAG-1 for degradation, it may be relevant hat Jurkat cells 
cotransfected with Bcl-2 and BAG-1 consistently con- 
tained higher relative levels of BAG-1 protein than cells 
transfected with BAG-1 alone, suggesting that the interac- 
tion of BAG-1 with Bcl-2 potentially could stabilize the 
BAG-1 protein (Figure 3; data not shown). Unlike the pro- 
tein ubiquitin, the function of the ubiquitin-like domains 
found in Gdx-1, Nedd-8, and other ubiquitin-like proteins 
is unknown. It has been speculated, however, that they 
may mediate protein-protein recognition (Toniolo et al., 
1988), and thus, the ubiquitin-like domain in BAG-1 theo- 
retically may participate in the binding of BAG-1 to Bcl-2 
or other proteins. Recent studies indicate that proteases 
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can be essential for induction of programmed cell death 
and apoptosis in a variety of physiological and pathological 
circumstances (Yuan et al., 1993; Miura et al., 1993; Sarin 
et al., 1994; Gagliardini et al., 1994). By analogy to the 
known role of covalent addition of ubiquitin in rendering 
target proteins recognizable by subunits of a large 26S 
proteasome, it is tempting to speculate that the BAG-1 
protein plays a role in bringing Bcl-2 or other Bcl-2-binding 
proteins into contact with a protease-containing protein 
complex that participates in cell death regulation. 
Previously it has been suggested that there exist both 
Bcl-2-dependent and Bcl-2-independent pathways for sup- 
pression of apoptosis, largely on the basis of gene transfer 
experiments where elevated levels of Bcl-2 protein produc- 
tion were shown to be insufficient to protect cells from 
induction of cell death by some kinds of stimuli. In particu- 
lar, it has been controversial whether high levels of Bcl-2 
protein correlate with resistance to apoptosis induced by 
anti-Fas antibodies and cytolytic T cells, with Bcl-2 appar- 
ently providing protection in some cell lines but not others 
(Itoh et al., 1993; Owen-Schaub et al., 1994; Vaux et al., 
1992a; Strasser et al., 1991; Torigoe et al., 1994b). The 
gene transfer experiments presented here, however, sug- 
gest that the failure of Bcl-2 to promote cell survival in at 
least some of these scenarios may have an explanation 
other than invoking the presence of a Bcl-2-independent 
pathway. In Jurkat T cells, for example, cotransfection of 
Bcl-2 and BAG-1 expression plasmids rendered these 
cells relatively more resistant to induction of cell death 
by staurosporine, anti-Fas antibody, and cytolytic T cells, 
whereas either Bcl-2 or BAG-1 alone was comparatively 
ineffective at providing protection from cell death. Clearly, 
therefore, the context in which BcI-2 is overexpressed is 
vitally important to its ability to block cell death. To the 
extent that partner proteins such as BAG-1 are present 
at insufficient levels or dominant inhibitors such as Bax or 
Bcl-xs are produced at excessive levels, a mere increase in 
Bcl-2 protein levels may be inadequate to protect some 
types of cells from some kinds of cell death stimuli. In these 
cases, the cell death pathway utilized may nevertheless 
directly involve a Bcl-2-regulable step. 
Experimental Procedures 
cDNA Library Screening 
A mouse embryo DNA library in ;~EX-Iox (Novagen, Incorporated) was 
plated on BL21(DE3) ceils and induced with isopropyl-~-o-thiogalac- 
topyranoside (IPTG) according to the protocol of the manufacturer, 
Filters were preblocked in Hyb75 solution (20 mM HEPES [pH 7,7], 
75 mM KCI, 2.5 mM MgCI2, 2 mM EDTA, 1 mM dithiothreitol [DTT], 
0.1% Triton X-100) containing 5% nonfat milk for 30 min and then 
incubated overnight at 4°C in Hyb75 containing 1 mM phenylmethyl- 
sulfonyl fluoride (PMSF), 1% milk, and 1% lysate from bcl-2-baculovi- 
rus-infected Sf9 cells (Reed et al., 1992; Newmeyer et al., 1994). After 
one wash for 5 rain in Hyb75, filters were incubated for 2 hr at 4°C 
in the same solution containing 1% nonfat milk and 0.1% (v/v) ascites 
from the anti-Bcl-2 antibody-producing hybridoma 4D7.4 (Reed et al., 
1992). Antibody detection was accomplished by using 0.14 ~g/ml 
alkaline phosphatase-conjugated rabbit anti-mouse IgG (Promega, 
Incorporated) in Hyb75 with 1% milk followed by 5-bromo-4-chloro-3- 
indolylphosphate toluidinium-nitroblue tetrazolium chloride (BCIP- 
NBT). To convert his phage to plasmid, BM25.8 cells that contain P1 
cre recombinase (Palazzolo et al., 1990) were infected and plated on 
ampicillin-containing LB plates. 
In addition, a mouse kidney cDNA library in Zgtl0 (Clontech, Incor- 
porated) was screened using the original bag-1 cDNA clone (pS33-1) 
as a 32P-labeled hybridization probe to obtain additional cDNA clones, 
of which ~.SN-245-9 contained nucleotides -82 to +843 bp. 
BAG-1 Fusion Proteins 
For GST-BAG-1 fusion protein, the bag-1 cDNA (pS33-1) was excised 
from pEX/ox-BAG-1 by digestion with EcoRI and Hindlll and sub- 
cloned into the EcoRI site of pGEX-3X (Pharmacia, Incorporated) by 
use of a HindllI-EcoRI adapter. The pGEX-3X and pGEX-3X-BAG-1 
plasmids were transformed into XLl-blue cells (Stratagene, Incorpo- 
rated). Overnight cultures were diluted 1:10 into LB medium containing 
50 p.g/ml ampicillin, and 2 hr later, 0.1-0.2 mM IPTG was added prior 
to incubating cultures 12-18 h r at 30 °C with aeration. Cells were recov- 
ered from 250 ml cultures by centrifugation, resuspended in - 10 ml of 
phosphate-buffered saline (PBS; pH 7.4) containing 1% Triton X-100, 
1 mM PMSF, and 1 mg/ml ysozyme, and sonicated on ice by using 
five bursts of 30 s each from a 1.6 mm tip (Ultrasonicator model XL- 
2020; Heat Systems, Incorporated). After centrifugation at 16,000 x 
g for 15-30 min, the supernatant was mixed with - 1 ml of glutathione- 
Sepharose-4B (Pharmacia, incorporated) for 1 hr at 4°C. The beads 
were then washed two times in PBS containing 1% Triton X-100, and 
the GST-BAG-1 and GST proteins were eluted by using 5 vol of 5 mM 
glutathione, 50 mM Tris [pH 8.0]. 
Filter binding assays were performed using -0.25 I~g of purified 
GST-BAG-1 and GST control proteins. After size fractionation of pro- 
teins by SDS-polyacrylamide gel electrophoresis (PAGE) and transfer 
to nitrocellulose, filters were processed as described above for library 
screening. For binding of Bcl-2 to GST-BAG-1 protein in solution, 
GST control or GST-BAG-1 proteins were immobilized on glutathione- 
Sepharose-4B ( -  0.25 p~g of protein/1 p.I of beads) that had been pre- 
blocked in 0.5% nonfat milk and 0.05% bovine serum albumin (BSA), 
and - 10-20 ~1 was incubated for 1 hr on a rotator at 4°C with 50 I~1 
of Sf9 cell lysates in 0.4 ml of binding buffer (20 mM Tris [pH 7.5], 
100 mM NaCI, 2 mM EDTA, 0.1% Nonidet P-40 [NP-40], 2 mM DTT, 
0.05% BSA, 50/0 glycerol). Sepharose beads were then washed three 
times in 1 ml of TENNS buffer (2.5 mM Tris [pH 7.4], 2.5 mM EDTA, 
250 mM NaCI, 1% NP-40, 2.5% sucrose), then resuspended in 20 I~1 
of Laemmli buffer, and 10 tll was analyzed by SDS-PAGE/immunoblot 
assay (12% gels) using 0.20/0 (v/v) of an anti-Bcl-2 rabbit antiserum 
(Reed et al., 1991) and alkaline phosphatase-conjugated goat anti- 
rabbit IgG (Promega, Incorporated), followed by NBT-BCIP in 0.1 M 
Tris [pH 9.5], 0.1 M NaCI, 5 mM MgCI2. 
Antibodies and Immunoblotting 
Antisera were prepared in rabbits essentially as described previously 
(Reed et al., 1991) by using a synthetic peptide corresponding to the 
C-terminal 16 amino acids of BAG-1 (NH2-CQETERLQSTNLALAE- 
COOH) that was conjugated to maleimide-activated keyhole limpet 
hemocyanin (KLH) (Pierce, Incorporated). For SDS-PAGE/immu- 
noblot assays, blots were preblocked in Tris-buffered saline (TBS; 20 
mM Tris [pH 7.5], 150 mM NaCI) containing both 3% BSA and 5% 
nonfat milk, and washes were performed using TBS containing 0.05% 
Triton X-100. Primary antibodies were used at 0.1%-0.2% (v/v), and 
detection was with 0.05% horseradish peroxidase-conjugated goat 
anti-rabbit IgG (Amersham, Incorporated) in TBS with 30/o BSA by the 
enhanced chemiluminescence (ECL) method (Amersham, Incorpo- 
rated). 
Gene Transfections 
For BALB/c 3T3 cells, the bag-1 cDNA SN-245-9 was subcloned into 
the Hindlll and Xbal sites of pRc/CMV (Invitrogen, Incorporated). Scal- 
linearized DNA (25 p~g) was mixed with 2.5 x 106 BALB/c 3T3 cells 
in 0.8 ml of Hanks' balanced salt solution (HBSS; 20 mM HEPES [pH 
7.05], 137 mM NaCI, 5 mM KCI, 0.7 mM Na2HPO4, 6 mM dextrose) 
on ice. Electroporations were performed in 0.4 cm (diameter) cuvettes 
with platinum electrodes using 270 V and 1500 I~F (Cell Ject; EquiBio, 
Incorporated). Selections were begun 2 days later using medium con- 
taining 1 mg/ml geneticin (GIBCO BRL, Incorporated), and individual 
clones were isolated using cloning cylinders. 
For Jurkat T cells, the bag-1 cDNA SN-245-9 in pSK-II was excised 
by use of Hindlll and BamHI and subcloned into pCEP (Invitrogen, 
Incorporated). Jurkat cells (5 x 106) were mixed with 25 I~g of plasmid 
Cell 
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DNA in 0.8 ml of HBSS and electroporated using 270 V and 900 p.F. 
After 2 days, cells were seeded at 10 s cells/ml in medium containing 
1 mg/ml hygromycin (Calbiochem, Incorporated). 
Cytotoxicity Assays 
Jurkat cells were cultured for various times at 5 × 105 cells/ml in 
96-well flat-bottomed plates (Falcon, Incorporated) (0.2 ml/well) con- 
taining 1 ~tg/ml 2D1 antibody (Takahashi et al., 1993), 10 ~M stauro- 
sporine (Sigma, Incorporated), or none of these reagents. BALB/c 3T3 
cells were cultured with or without 1 I~M staurospodne at 104 ceils per 
flat-bottomed well. Relative numbers or percentages of viable cells 
were determined by trypan blue dye exclusion or 3[4,5-dimethylthiazol- 
2-yl]-2,5-diphenyltetrazolium bromide (MTT) dye reduction assay as 
described previously (Kitada et al., 1994). For CTL experiments, Jurkat 
cells were labeled with S~Cr and cultured for 4 hr with CTLs at an E/T 
ratio of 20/1. The percentage specific S~Cr elease was then calculated 
by correction for spontaneous release and normalization for total re- 
lease induced by 1% NP-40 as described (Torigoe et al., 1994a, 
1994b). 
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